Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vaccine delivery--current trends and future.

Neelam Azad1, Yon Rojanasakul

  • 1West Virginia University, School of Pharmacy, Department of Pharmaceutical Sciences, Morgantown, WV 26506, USA.

Current Drug Delivery
|April 14, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reversible Upregulation of the Senescence-Associated Beta-Galactosidase Marker Induced by Cell Detachment in Cancer Cells.

Cells·2025
Same author

Prolonged Low-Dose Administration of FDA-Approved Drugs for Non-Cancer Conditions: A Review of Potential Targets in Cancer Cells.

International journal of molecular sciences·2025
Same author

Anti-TIM3 chimeric antigen receptor-natural killer cells preferentially target primitive acute myeloid leukemia cells with minimal fratricide and exhaustion.

Experimental hematology & oncology·2024
Same author

A Short Post-Reattachment Ultrasensitive Window of Time in Human Cancer Cells as Therapeutic Target of Prolonged Low-Dose Administration of Specific Compounds.

International journal of cell biology·2024
Same author

Musashi-2 in cancer-associated fibroblasts promotes non-small cell lung cancer metastasis through paracrine IL-6-driven epithelial-mesenchymal transition.

Cell & bioscience·2023
Same author

Cardiac glycoside ouabain efficiently targets leukemic stem cell apoptotic machinery independent of cell differentiation status.

Cell communication and signaling : CCS·2023

Novel vaccine delivery systems aim to overcome challenges in developing effective vaccines for diseases like AIDS and malaria. Exploring non-parenteral routes, such as oral or intranasal, offers a promising future for global immunization strategies.

Area of Science:

  • Vaccinology
  • Biotechnology
  • Immunology

Background:

  • Vaccines, since Edward Jenner's discovery in 1796, have significantly impacted infectious disease therapeutics.
  • Despite advances in proteomics, genomics, and biotechnology, challenges persist in developing vaccines for diseases like AIDS, malaria, and hepatitis C.
  • Technological and economic hurdles impede vaccine development, highlighting the need for stable, economical, and easily administered vaccines.

Purpose of the Study:

  • To review current developments in novel vaccine delivery systems.
  • To explore non-parenteral routes for vaccine administration.
  • To address the need for improved vaccine formulations and delivery methods.

Main Methods:

  • Review of current research in vaccine delivery technologies.

Related Experiment Videos

  • Evaluation of non-parenteral administration routes (oral, intranasal, transcutaneous, intradermal).
  • Assessment of novel systems including DNA vaccines, adjuvants, microparticles, and transgenic plants.

    • Main Results:

    • Non-parenteral vaccine delivery systems show potential for reducing needle-borne disease risks.
    • These novel systems may decrease the need for trained personnel and sterile equipment.
    • Current research indicates these systems could advance immunization to a new technological level.

    Conclusions:

    • Effective vaccine formulation and delivery are crucial for therapeutic success.
    • Novel vaccine delivery systems and non-parenteral routes are a global priority.
    • While no major breakthroughs are imminent, ongoing research holds promise for future vaccine development.